Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.26% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CTKB · Sep 30, 2025
Cytek Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-25-049697General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-7.45% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
1.54% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
98.77% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
52.69% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-17.58% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
17.13% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
10.78% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Sep 30, 20210/7 normalizedLevel 3Dec 31, 20210/7 normalizedLevel 3Mar 31, 20220/7 normalizedLevel 3Jun 30, 20220/8 normalizedLevel 3Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20235/8 normalizedLevel 3Sep 30, 20237/8 normalizedLevel 3Dec 31, 20237/8 normalizedLevel 3Mar 31, 20247/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 3.46%
- Current
- 1.26%
- Delta
- -2.20%
- Previous
- 0.24%
- Current
- -7.45%
- Delta
- -7.69%
- Previous
- -2.18%
- Current
- 1.54%
- Delta
- 3.72%
- Previous
- 108.52%
- Current
- 98.77%
- Delta
- -9.75%
- Previous
- 52.34%
- Current
- 52.69%
- Delta
- 0.35%
- Previous
- -23.30%
- Current
- -17.58%
- Delta
- 5.72%
- Previous
- 19.35%
- Current
- 17.13%
- Delta
- -2.23%
- Previous
- 14.89%
- Current
- 10.78%
- Delta
- -4.11%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CTKB Fundamental State →Transitioned To · CTKB Fundamental State →Transitioned To · CTKB CAPEX_INTENSITY_DECREASED →Transitioned To · CTKB CASH_GENERATION_DECREASED →Transitioned To · CTKB GROWTH_INCREASED →Transitioned To · CTKB INVENTORY_PRESSURE_DECREASED →Transitioned To · CTKB MARGIN_INCREASED →Transitioned To · CTKB PROFITABILITY_INCREASED →Transitioned To · CTKB R_AND_D_INTENSITY_DECREASED →Transitioned To · CTKB SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.